Replies to post #198268 on Enzolytics Inc (ENZC)

[Valuator2]

I know that date by accident actually. I look at the ENZC OTCMarkets pages and sometimes take a picture of the Securities page just to be able to spot a timeframe of a change in the balances. I happened to take a picture of the 4/15/24 page, so I took another picture the next day when I saw the change in the O/S balance. LOL, these iphones are pretty handy.

You're right they could have disclosed the 145 million new shares somewhere in the 3Q report, maybe as a subsequent event, but I'm not sure they had an obligation to do it. The question is who got those shares. One possibility is that Austin may have gotten the 56,600,000 (up from 14 mill) for the $236K loan, leaving 89+million shares to account for.

I see some inconsistencies in the fins and reports quite often. Like I've said several times, an inhouse qualified CFO could catch most, if not all, of those inconsistencies before filing the reports. Since we're talking about the O/S common stock, for example, here's one in the Equity section of the 3Q Balance Sheet re the A/S. Looks like a sloppy review in this case and a reader can probably see it's an oversight, but other mistakes or inconsistencies from time to time may be due to some other reason (JMHO):

Common stock, $.0001 par value; 3,000,000,000 shares
authorized, 3,187,974,257 and 3,172,974,257 issued and
outstanding at March 31, 2024 and December 31, 2023,
respectively